Double-blind, placebo-controlled phase IIb French trial of BTI 320 [PAZ 320] in patients with type 2 diabetes mellitus who are being treated with metformin

Trial Profile

Double-blind, placebo-controlled phase IIb French trial of BTI 320 [PAZ 320] in patients with type 2 diabetes mellitus who are being treated with metformin

Recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Oct 2014

At a glance

  • Drugs BTI 320 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Boston Therapeutics
  • Most Recent Events

    • 09 Oct 2014 Study stated to be ongoing, according to a Boston Therapeutics media release.
    • 12 Nov 2013 Status changed from planning to recruiting. Patient enrolment has begun, according to a Boston Therapeutics media release.
    • 14 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top